|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01612 VINCENT MED
Nominal 
0.400 +0.005 (+1.266%) | 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Turnover | 380,706 | 5.390% | 717,973 | 629,242 | 777,720 | 1,155,383 |
| Cost of Sales | (261,525) | 7.886% | (477,586) | (463,889) | (518,616) | (661,146) |
| Gross Profit | 119,181 | 0.299% | 240,387 | 165,353 | 259,104 | 494,237 |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (163) | -- | 2,817 | (1,664) | (5,879) | (4,753) | |
| Profit / (Loss) before Taxation | 33,860 | 4.606% | 66,915 | (15,516) | 66,180 | 284,084 | |
| Taxation | (299) | -94.332% | (8,707) | (2,874) | (6,110) | (36,649) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (273) | -44.737% | (933) | 992 | 625 | (30,570) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 33,288 | 25.143% | 57,275 | (17,398) | 60,695 | 216,865 | |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Finance Costs / (Income) | (138) | -- | 985 | 2,342 | 2,046 | 3,167 |
| Depreciation & Amortisation | 17,774 | -10.440% | 38,331 | 40,952 | 40,063 | 37,016 |
| Directors' Emoluments | 3,586 | 2.253% | 6,856 | 7,245 | 6,912 | 11,081 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 5.170 | 26.098% | 8.870 | -2.660 | 9.280 | 33.840 |
| DPS (cts) | 1.600 | -- | 2.750 | 2.500 | 4.500 | 11.000 |
| Dividend Payout Ratio (%) | 30.948% | -- | 31.003% | -- | 48.491% | 32.506% |
| Cash flow per share ($) | -- | -- | 0.194 | 0.116 | 0.182 | 0.325 |
| NBV per share ($) | 0.864 | -- | 0.829 | 0.762 | 0.914 | 0.940 |
| Remarks: | Real time quote last updated: 28/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 33,288,000 |
| %Change | 25.143% |
| EPS / (LPS) | HKD 0.052 |
| NBV Per Share ($) | HKD 0.864 |